Your browser doesn't support javascript.
loading
Early molecular response with Imatinib therapy in chronic Myeloid Leukemia and its association with baseline white blood cell count and Spleen size
PAFMJ-Pakistan Armed Forces Medical Journal. 2018; 68 (5): 1199-1204
in English | IMEMR | ID: emr-206445
ABSTRACT

Objectives:

To determine the frequency of early molecular response in patients of chronic myeloid leukemia treated with Imatinib and its association with baseline white blood cell [WBC] count and spleen size
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Pak. Armed Forces Med. J. Year: 2018

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Pak. Armed Forces Med. J. Year: 2018